Elena Conci was an Honorary Clinical Research Fellow at MitoCAMB between August 2023 to August 2024, when she contributed as a sub-investigator to several studies: Falcon (Abliva), SPIMD-301 (Stealth BioTherapeutics) and Mitox (MBU, University of Cambridge) trials focusing on primary mitochondrial diseases, as well as the Define (MBU, University of Cambridge) trial aimed at addressing neuroferritinopathy.
She earned her medical degree (MB BChir) from the University of Cambridge in 2018, which included an integrated master’s in Neuroscience (MA). Following this, she joined the Academic Foundation Programme at Cambridge University Hospitals. Here, she conducted imaging-based research on organoid models of Amyotrophic Lateral Sclerosis (ALS) under the mentorship of Dr. Andas Lakatos at the John van Geest Centre for Brain Repair.
Elena successfully completed her training in Internal Medicine (MRCP) and continues to practice as a Neurology Registrar in the East of England deanery. Her research interests lie at the intersection of computational biology and neurology, particularly mitochondrial, neurogenetic and neurodegenerative disease.
Publications
- Szebényi K, Wenger L, Sun Y, Dunn A, Limegrover C, Gibbons G, Conci E, Paulsen O, Mierau S, Balmus G, Lakatos A (2021). Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nature Neuroscience. PubMed ID: 34675437
- Raffan E, Dennis R, O’Donovan C, Becker J, Scott R, Smoth S, Withers D, Wood C, Conci E, Clements D, Summete K, German A, Mellersh C, Arendt M, Iyemere V, Withers E, Söder J, Wernersson S, Andersson G, Lindbland-Toh K, Yeo G, O’Rahilly S (2016). A deletion in canine POMC gene and its relationship to the obesity-proneness of Labrador retriever dogs. Cell Metabolism. PubMed ID: 27157046